Transthyretin amyloidosis: Putting myopathy on the map

Marcus V. Pinto, Margherita Milone, Michelle L. Mauermann, P. James B. Dyck, Reem Alhammad, Ellen D. McPhail, Martha Grogan, Teerin Liewluck

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction: Although peripheral neuropathy and cardiomyopathy are well-recognized manifestations of transthyretin (ATTR) amyloidosis, myopathy has been rarely reported. Methods: In this study we reviewed our muscle biopsy database (January 1998 to June 2018) to identify patients with ATTR amyloid myopathy confirmed by molecular or proteomic analysis. Clinical and laboratory findings were reviewed. Results: We identified eight ATTR amyloid myopathy patients (5 hereditary ATTR [ATTRv] and 3 wild-type ATTR [ATTRwt]). Myopathy was the initial manifestation in all ATTRwt patients and followed peripheral neuropathy (4 patients) or cardiomyopathy (1 patient) in ATTRv patients. One ATTRv patient developed myopathy after liver transplant. Peripheral neuropathy and cardiac amyloidosis occurred in seven and six patients, respectively. Muscle biopsy showed interstitial amyloid deposition in all patients, rare necrotic/regenerating fibers in six, and vacuoles in four. Discussion: Myopathy can be the initial manifestation of ATTRwt amyloidosis and can precede the peripheral neuropathy or occur after liver transplant in ATTRv amyloidosis.

Original languageEnglish (US)
JournalMuscle and Nerve
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Muscular Diseases
Peripheral Nervous System Diseases
Amyloidosis
Amyloid
Cardiomyopathies
Transplants
Biopsy
Amyloidosis, Hereditary, Transthyretin-Related
Muscles
Liver
Vacuoles
Proteomics
Databases

Keywords

  • amyloid myopathy
  • ATTR amyloid myopathy
  • ATTR amyloidosis
  • myopathy
  • neuromyopathy
  • transthyretin amyloidosis

ASJC Scopus subject areas

  • Physiology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)

Cite this

Transthyretin amyloidosis : Putting myopathy on the map. / Pinto, Marcus V.; Milone, Margherita; Mauermann, Michelle L.; Dyck, P. James B.; Alhammad, Reem; McPhail, Ellen D.; Grogan, Martha; Liewluck, Teerin.

In: Muscle and Nerve, 01.01.2019.

Research output: Contribution to journalArticle

@article{69ff20eade064dd5a77d09d764b3a845,
title = "Transthyretin amyloidosis: Putting myopathy on the map",
abstract = "Introduction: Although peripheral neuropathy and cardiomyopathy are well-recognized manifestations of transthyretin (ATTR) amyloidosis, myopathy has been rarely reported. Methods: In this study we reviewed our muscle biopsy database (January 1998 to June 2018) to identify patients with ATTR amyloid myopathy confirmed by molecular or proteomic analysis. Clinical and laboratory findings were reviewed. Results: We identified eight ATTR amyloid myopathy patients (5 hereditary ATTR [ATTRv] and 3 wild-type ATTR [ATTRwt]). Myopathy was the initial manifestation in all ATTRwt patients and followed peripheral neuropathy (4 patients) or cardiomyopathy (1 patient) in ATTRv patients. One ATTRv patient developed myopathy after liver transplant. Peripheral neuropathy and cardiac amyloidosis occurred in seven and six patients, respectively. Muscle biopsy showed interstitial amyloid deposition in all patients, rare necrotic/regenerating fibers in six, and vacuoles in four. Discussion: Myopathy can be the initial manifestation of ATTRwt amyloidosis and can precede the peripheral neuropathy or occur after liver transplant in ATTRv amyloidosis.",
keywords = "amyloid myopathy, ATTR amyloid myopathy, ATTR amyloidosis, myopathy, neuromyopathy, transthyretin amyloidosis",
author = "Pinto, {Marcus V.} and Margherita Milone and Mauermann, {Michelle L.} and Dyck, {P. James B.} and Reem Alhammad and McPhail, {Ellen D.} and Martha Grogan and Teerin Liewluck",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/mus.26723",
language = "English (US)",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Transthyretin amyloidosis

T2 - Putting myopathy on the map

AU - Pinto, Marcus V.

AU - Milone, Margherita

AU - Mauermann, Michelle L.

AU - Dyck, P. James B.

AU - Alhammad, Reem

AU - McPhail, Ellen D.

AU - Grogan, Martha

AU - Liewluck, Teerin

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Introduction: Although peripheral neuropathy and cardiomyopathy are well-recognized manifestations of transthyretin (ATTR) amyloidosis, myopathy has been rarely reported. Methods: In this study we reviewed our muscle biopsy database (January 1998 to June 2018) to identify patients with ATTR amyloid myopathy confirmed by molecular or proteomic analysis. Clinical and laboratory findings were reviewed. Results: We identified eight ATTR amyloid myopathy patients (5 hereditary ATTR [ATTRv] and 3 wild-type ATTR [ATTRwt]). Myopathy was the initial manifestation in all ATTRwt patients and followed peripheral neuropathy (4 patients) or cardiomyopathy (1 patient) in ATTRv patients. One ATTRv patient developed myopathy after liver transplant. Peripheral neuropathy and cardiac amyloidosis occurred in seven and six patients, respectively. Muscle biopsy showed interstitial amyloid deposition in all patients, rare necrotic/regenerating fibers in six, and vacuoles in four. Discussion: Myopathy can be the initial manifestation of ATTRwt amyloidosis and can precede the peripheral neuropathy or occur after liver transplant in ATTRv amyloidosis.

AB - Introduction: Although peripheral neuropathy and cardiomyopathy are well-recognized manifestations of transthyretin (ATTR) amyloidosis, myopathy has been rarely reported. Methods: In this study we reviewed our muscle biopsy database (January 1998 to June 2018) to identify patients with ATTR amyloid myopathy confirmed by molecular or proteomic analysis. Clinical and laboratory findings were reviewed. Results: We identified eight ATTR amyloid myopathy patients (5 hereditary ATTR [ATTRv] and 3 wild-type ATTR [ATTRwt]). Myopathy was the initial manifestation in all ATTRwt patients and followed peripheral neuropathy (4 patients) or cardiomyopathy (1 patient) in ATTRv patients. One ATTRv patient developed myopathy after liver transplant. Peripheral neuropathy and cardiac amyloidosis occurred in seven and six patients, respectively. Muscle biopsy showed interstitial amyloid deposition in all patients, rare necrotic/regenerating fibers in six, and vacuoles in four. Discussion: Myopathy can be the initial manifestation of ATTRwt amyloidosis and can precede the peripheral neuropathy or occur after liver transplant in ATTRv amyloidosis.

KW - amyloid myopathy

KW - ATTR amyloid myopathy

KW - ATTR amyloidosis

KW - myopathy

KW - neuromyopathy

KW - transthyretin amyloidosis

UR - http://www.scopus.com/inward/record.url?scp=85074495814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074495814&partnerID=8YFLogxK

U2 - 10.1002/mus.26723

DO - 10.1002/mus.26723

M3 - Article

C2 - 31587306

AN - SCOPUS:85074495814

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

ER -